These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16722550)

  • 41. Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users.
    Wood E; Kerr T; Lloyd-Smith E; Buchner C; Marsh DC; Montaner JS; Tyndall MW
    Harm Reduct J; 2004 Nov; 1(1):9. PubMed ID: 15535885
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV seroprevalence among participants at a Supervised Injection Facility in Vancouver, Canada: implications for prevention, care and treatment.
    Tyndall MW; Wood E; Zhang R; Lai C; Montaner JS; Kerr T
    Harm Reduct J; 2006 Dec; 3():36. PubMed ID: 17176481
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Public injecting among a cohort of injecting drug users in Vancouver, Canada.
    DeBeck K; Small W; Wood E; Li K; Montaner J; Kerr T
    J Epidemiol Community Health; 2009 Jan; 63(1):81-6. PubMed ID: 18628270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decline in needle exchange use in Vancouver, Canada coincides with the Australian heroin shortage.
    Small W; Wood E; Buchner C; Fair B; Kerr T
    Int J Drug Policy; 2008 Aug; 19(4):291-2; discussion 295-6. PubMed ID: 18424114
    [No Abstract]   [Full Text] [Related]  

  • 45. The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs.
    DeBeck K; Kerr T; Lai C; Buxton J; Montaner J; Wood E
    Am J Drug Alcohol Abuse; 2012 Jan; 38(1):55-62. PubMed ID: 21834612
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IDU perspectives on the design and operation of North America's first medically supervised injection facility.
    Small W; Ainsworth L; Wood E; Kerr T
    Subst Use Misuse; 2011; 46(5):561-8. PubMed ID: 20874006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estimating the size and dynamics of an injecting drug user population and implications for health service coverage: comparison of indirect prevalence estimation methods.
    Kimber J; Hickman M; Degenhardt L; Coulson T; van Beek I
    Addiction; 2008 Oct; 103(10):1604-13. PubMed ID: 18638037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Going soft on evidence and due process: Canada adopts US style harm maximization.
    Wodak A
    Int J Drug Policy; 2008 Jun; 19(3):226-8; discussion 233-4. PubMed ID: 18424112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crime in hospitals 1993--the latest IAHSS survey.
    Stultz MS
    J Healthc Prot Manage; 1994-1995 Winter; 11(1):1-41. PubMed ID: 10139274
    [TBL] [Abstract][Full Text] [Related]  

  • 50. "I inject less as I have easier access to pipes": injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed.
    Leonard L; DeRubeis E; Pelude L; Medd E; Birkett N; Seto J
    Int J Drug Policy; 2008 Jun; 19(3):255-64. PubMed ID: 18502378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Injecting-related injury and disease among clients of a supervised injecting facility.
    Salmon AM; Dwyer R; Jauncey M; van Beek I; Topp L; Maher L
    Drug Alcohol Depend; 2009 Apr; 101(1-2):132-6. PubMed ID: 19167171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ambivalence about supervised injection facilities among community stakeholders.
    Strike C; Watson TM; Kolla G; Penn R; Bayoumi AM
    Harm Reduct J; 2015 Aug; 12():26. PubMed ID: 26292715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Violent crime and substance abuse: a medico-legal comparison between deceased users of anabolic androgenic steroids and abusers of illicit drugs.
    Klötz F; Petersson A; Isacson D; Thiblin I
    Forensic Sci Int; 2007 Nov; 173(1):57-63. PubMed ID: 17337333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. America's Soaring Prison Population.
    Langan PA
    Science; 1991 Mar; 251(5001):1568-73. PubMed ID: 17793140
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug crime is a source of abused pain medications in the United States.
    Joranson DE; Gilson AM
    J Pain Symptom Manage; 2005 Oct; 30(4):299-301. PubMed ID: 16256890
    [No Abstract]   [Full Text] [Related]  

  • 56. Harm reduction headway and continuing resistance: insights from safe injection in the city of Vancouver.
    Hathaway AD; Tousaw KI
    Int J Drug Policy; 2008 Feb; 19(1):11-6. PubMed ID: 18164610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
    McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
    Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Individual dollar expenditure and earnings from cannabis in the New Zealand population.
    Wilkins C; Sweetsur P
    Int J Drug Policy; 2007 May; 18(3):187-93. PubMed ID: 17689365
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thinking ethically about needle and syringe programs.
    Kleinig J
    Subst Use Misuse; 2006; 41(6-7):815-25. PubMed ID: 16809168
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Public injection settings in Vancouver: physical environment, social context and risk.
    Small W; Rhodes T; Wood E; Kerr T
    Int J Drug Policy; 2007 Jan; 18(1):27-36. PubMed ID: 17689341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.